Sofwave Reports Fifth Consecutive Profitable Quarter, CEO to Receive $4.3 Million in Stock Units
Sofwave, the medical aesthetics company founded by Dr. Shimon Eckhouse, reported a record $30 million in revenue for the second quarter of 2026, alongside a 67% increase in net profit. This marks the fifth consecutive profitable quarter for the company. Since June 2023, when its market value hit a low of $239 million, Sofwave's stock has surged 482%, raising its market capitalization to approximately 1.5 billion shekels.
In light of these strong results, Sofwave plans to grant its CEO, Louis Scafuri, 369,000 performance stock units (PSUs) valued at 15 million shekels. This allocation would increase his annual compensation to 8.35 million shekels, exceeding the company's usual remuneration policy. The shareholders' meeting next month will vote on this proposal. Scafuri, who has led the company since 2019 and oversaw its 2021 Tel Aviv Stock Exchange listing, transformed Sofwave from a development-stage firm with heavy R&D expenses into a profitable company with growing revenues.
Sofwave develops and markets medical devices for wrinkle treatment, skin rejuvenation, and tightening, selling both the equipment and virtual pulse packages required for each treatment session. These pulse sales generated $13.9 million in the second quarter, a 52% increase year-over-year, accounting for 46% of total quarterly revenue. The CEO’s stock units will vest in three equal annual tranches, exercisable at 30 agorot per share, 26% below the recent closing price, contingent on the company meeting revenue and EBITDA targets set by the board. Scafuri may exercise half the units if the company achieves at least 80% of these goals.
The company’s improved performance and investor interest were partly boosted by celebrity endorsements, including Kim Kardashian’s public use of Sofwave’s skin tightening treatments. Dr. Eckhouse remains the largest shareholder with 23.5% ownership and serves as chairman.
Summary: Sofwave posted a record $30 million revenue and 67% profit growth in Q2 2026, marking its fifth profitable quarter. CEO Louis Scafuri is set to receive stock units worth 15 million shekels, pending shareholder approval, reflecting the company’s strong market performance and growth trajectory.